Nurse Practitioner, Family · Oak Lawn, IL
NPI
1700254703
Since 2015
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
4440 W 95th St Ste 6409
Oak Lawn, IL, 60453
Phone (877) 684-4327
Groups this clinician bills Medicare through
Medicare paid, 2024
$9,687
197 services
Medicare patients, 2024
123
Average age 75
Drug cost, 2024
$6.7M
2,661 prescriptions
Company payments, 2025
$2,757
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kathleen M Kamba was code 99214 (office e&m - established), 93 times for 70 patients. In total Kathleen M Kamba billed 197 services in 11 codes, and Medicare paid $9,687.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 93 | 70 | $60.02 | $5,581 |
| 99213 Office E&M - Established | Facility | 45 | 40 | $43.06 | $1,938 |
| 93264 External Electrocardiographic Monitoring | Facility | 29 | 11 | $22.47 | $652 |
By year: 2022 $9,767 for 204 services; 2023 $9,101 for 210 services; 2024 $9,687 for 197 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kathleen M Kamba prescribed most often to Medicare patients was Spironolactone, with 334 prescriptions and refills. In total Kathleen M Kamba wrote 2,661 Medicare prescriptions that cost $6.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Spironolactone Generic | 334 | 811 | 160 | $1,982 |
| Torsemide Generic | 288 | 592 | 124 | $8,274 |
| Entresto Sacubitril/Valsartan | 275 | 445 | 92 | $285K |
| Jardiance Empagliflozin | 225 | 349 | 79 | $207K |
| Potassium Chloride Generic | 220 | 465 | 94 | $4,910 |
| Vyndamax Tafamidis | 205 | 205 | 28 | $4.7M |
| Metoprolol Succinate Generic | 164 | 389 | 80 | $1,906 |
| Furosemide Generic | 161 | 335 | 83 | $888 |
| Carvedilol Generic | 125 | 282 | 55 | $1,279 |
| Farxiga Dapagliflozin Propanediol | 82 | 132 | 30 | $73K |
| Losartan Potassium Generic | 74 | 170 | 32 | $393 |
| Hydralazine Hcl Generic | 66 | 133 | 32 | $708 |
| Amlodipine Besylate Generic | 42 | 92 | 14 | $277 |
| Eliquis Apixaban | 33 | 69 | 14 | $40K |
| Klor-Con M20 Potassium Chloride | 30 | 63 | 20 | $988 |
Brand drugs: - claims; generic drugs: 1,738 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kathleen M Kamba $2,757 ($2,757 in general payments such as food, travel and fees) from 14 companies. The largest payer was BridgeBio Pharma, Inc. with $952.
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. BBIO | 8 | $952 |
| Abbott Laboratories ABT | 6 | $387 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $337 |
| AstraZeneca Pharmaceuticals LP AZN | 13 | $283 |
| Scpharmaceuticals Inc. SCPH | 5 | $192 |
| Pfizer Inc. PFE | 6 | $184 |
| Novo Nordisk Inc NVO | 1 | $121 |
| Alnylam Pharmaceuticals Inc. ALNY | 3 | $68.71 |
| CVRx, Inc. CVRX | 1 | $68.09 |
| Merck Sharp & Dohme LLC MRK | 4 | $65.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.